Pharmaids Pharmaceuticals Ltd
PHARMAIDBSE
₹30.00▼ -0.17 (-0.56%)
Whole company worth₹110 Cr
ProfitLoss-making
1-year range₹26 – ₹54
The short version
Pharmaids Pharmaceuticals, in seven plain questions.
What Pharmaids Pharmaceuticals does
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services. It is undergoing a business transition and aims to build a CRDMO platform.
Worked out from Pharmaids Pharmaceuticals's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Pharmaids Pharmaceuticals is a micro-sized company in pharmaceuticals.
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services. It is undergoing a business transition and aims to build a CRDMO platform.
- Whole company is worth
- ₹110 crore
- Shareholders
- 8,720 people
- Listed since
- 1994
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales grew 43% last year.
There is not enough history yet to judge Pharmaids Pharmaceuticals's growth over several years.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
For every ₹100 it sells, it spends ₹141.
Here is where the money from Pharmaids Pharmaceuticals's sales went in FY26, the latest full year it has reported.
₹62
₹60
₹13
₹100 of sales ends here
- ₹62Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹60Running the businessstaff, rent, marketing, power and everything else
- ₹13Interest on its loansthe cost of borrowed money
- ₹7.3Wear and tearmachines, stores and buildings losing value over time
- ₹41Lossspent beyond what came in — covered by savings or new money
It also received a tax credit of ₹4.7 crore that year, which is why tax is missing from the bar.
On the money its owners have put in
It lost ₹25 for every ₹100 its owners have invested.
Bank FD ~₹6–7
₹-25
₹-30₹-20₹-10₹0₹10₹20₹30₹40
Return on equity (ROE) measures the yearly profit made on the money shareholders have put into the business. Negative means the business is eating into that money.
04Is the price high or low?
Pharmaids Pharmaceuticals made a loss, so there is no "price for profit" to measure.
Investors are paying for what they hope it will earn later, not what it earns today. That makes the price harder to judge and more sensitive to news.
The share price over the past year
It is 44% below its highest price of the past year and 17% above its lowest.
05Who owns it?
Its founders and parent group own 33 of every 100 shares — a large stake, though not a majority.
If the company were split into 100 equal shares, this is who would hold them. 8,720 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
The figures raise more questions than they answer.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
Nothing stands out in its favour in the figures we have.
Worth watching
- Lost ₹12 crore in its last financial year.
- Thinly traded — only about ₹1 lakh of shares change hands a day, so buying or selling can move the price.
- The share price is 44% below its high of the past year.
07What happened lately?
Latest quarter: sales down 38%, profit up 135%.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹4.1 Cr
▼ 38.1% on a year earlier
Profit
₹1.9 Cr
▲ 135.2% on a year earlier
30 Sept 2026
The company reported a net loss of ₹12 crore for the latest financial year, which is an improvement compared to the prior year loss of ₹14 crore.
30 Jun 2026
The latest quarter showed a significant turnaround, with net profit turning positive at ₹2 crore, reversing a ₹5 crore loss in the same quarter a year earlier.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Pharmaids Pharmaceuticals?
This page describes Pharmaids Pharmaceuticals using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Pharmaids Pharmaceuticals Ltd (PHARMAID): company summary
The company's annual revenue rose 43.3% to ₹28 crore, but net profit remained a loss of ₹12 crore, narrowing from a ₹14 crore loss.
Pharmaids Pharmaceuticals Ltd (PHARMAID) is a micro-cap Healthcare company valued at ₹110 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Pharmaids Pharmaceuticals Ltd last traded at ₹30, modestly down 0.56% on the day.
- Recent developments
- 2026-09-30: The company reported a net loss of ₹12 crore for the latest financial year, which is an improvement compared to the prior year loss of ₹14 crore. 2026-06-30: The latest quarter showed a significant turnaround, with net profit turning positive at ₹2 crore, reversing a ₹5 crore loss in the same quarter a year earlier.
- Financial performance
- The company's annual revenue rose 43.3% to ₹28 crore, but net profit remained a loss of ₹12 crore, narrowing from a ₹14 crore loss. The latest quarter saw a sharp drop in revenue of 38.1% to ₹4 crore, but net profit swung from a ₹5 crore loss to a ₹2 crore profit.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.23 times book value.
- Things to watch
- The company's net profit margin remains negative at -41.5%, though it has improved from -69.4% a year ago. The stock is 44.0% below its 52-week high, and the latest quarter's revenue decline of 38.1% raises concerns about recent performance. The return on equity and return on capital employed are both negative, indicating ongoing challenges with profitability.
- Where it stands
- Pharmaids Pharmaceuticals Ltd ended its latest quarter with a net profit of ₹2 crore, reversing a loss, but revenue fell 38.1% compared to the same quarter a year earlier. The company's net loss narrowed to ₹12 crore in the latest financial year, but its return on equity and return on capital employed remain negative. The stock is 44.0% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Healthcare stocks · Pharmaceuticals
Explore Pharmaids Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Pharmaids Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Pharmaids Pharmaceuticals Ltd with peers
Pharmaids Pharmaceuticals Ltd vs Sun Pharmaceutical Industries LimitedPharmaids Pharmaceuticals Ltd vs Divi's Laboratories LimitedPharmaids Pharmaceuticals Ltd vs Torrent Pharmaceuticals LimitedPharmaids Pharmaceuticals Ltd vs Laurus Labs LimitedPharmaids Pharmaceuticals Ltd vs Zydus Lifesciences LimitedPharmaids Pharmaceuticals Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Pharmaids Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing